• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Stimulant treatment in healthy young people with ADHD is not associated with increased risk of cardiovascular events

Question

Question: Is stimulant treatment associated with an increased risk of cardiovascular events in young people with attention deficit hyperactive disorder (ADHD)?

People: 171 126 youths between the age of 6 and 21 years without known cardiovascular risk factors, who had ADHD and were enrolled in a health plan with pharmacy coverage. Participants were those who had an initial first or second listed service claim for ADHD (ICD-9 code 314) after a period of eligibility of at least 180 days without an ADHD medical claim diagnosis and without any prescriptions for stimulants. Individuals were excluded if they had received a diagnosis of any of a list of ‘high-risk exclusion conditions’ or ‘high-risk censored events’ during the 180-day eligibility period. These conditions and events related to underlying general medical disorders that might increase risk of cardiovascular events or might affect the availability of information on the individual.

Setting: MarketScan…

Posted in: Journal Article Abstracts on 08/10/2012 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice